Medicare drug coverage
Wegovy in North Dakota: 2027 Part D coverage
26 of 26 Part D plans offered in North Dakota (100%) list Wegovy on their 2027 formulary, the plan's list of covered drugs. 100% of those require prior authorization, step therapy, or a quantity limit. Plan counts include both Medicare Advantage plans with drug coverage (17 MA-PD) and stand-alone drug plans (9 PDP).
License: a US government work, in the public domain (Public Domain Mark 1.0).
For pharmacies and agencies: check a whole drug list against 2027 formularies.
Upload your patient list or your book of clients and Rivvi checks each drug against the CMS 2027 formulary files, plan by plan, so you see tier changes and new limits before the next refill or open enrollment. Free to start. HIPAA BAA included.
Every 2027 plan in North Dakota
Each Part D plan offered in North Dakota, with Wegovy's 2026 and 2027 tier and its 2027 limits. A tier is the cost level a plan puts a drug on; a lower tier usually costs less. Enter a ZIP to see only the plans offered in that county.
PA is prior authorization (the plan must approve it first), ST is step therapy (try another drug first), and QL is a quantity limit. D-SNP, C-SNP, and I-SNP are Special Needs Plans: for people with both Medicare and Medicaid, with certain chronic conditions, or who live in a nursing home or need that level of care. Plans are listed by plan ID.
| Plan | Plan ID | Type | 2026 tier | 2027 tier | 2027 PA / ST / QL | Change |
|---|---|---|---|---|---|---|
| Aetna Medicare Signature Classic Extra (PPO) | H1608-081-000 | MA-PD (PPO) | Not listed | Tier 3 | PA, QL | Newly listed |
| Great Plains Medicare Advantage (HMO I-SNP) | H1787-001-000 | MA-PD (HMO I-SNP) | Not listed | Tier 3 | PA, QL | Newly listed |
| Great Plain Medicare Advantage Gold (HMO I-SNP) | H1787-002-000 | MA-PD (HMO I-SNP) | Not listed | Tier 3 | PA, QL | Newly listed |
| UHC Dual Complete ND-S1 (PPO D-SNP) | H2001-085-000 | MA-PD (PPO D-SNP) | Not listed | Tier 3 | PA, QL | Newly listed |
| AARP Medicare Advantage from UHC FG-0001 (PPO) | H2001-118-000 | MA-PD (PPO) | Not listed | Tier 3 | PA, QL | Newly listed |
| AARP Medicare Advantage from UHC FG-0002 (PPO) | H2001-119-000 | MA-PD (PPO) | Not listed | Tier 3 | PA, QL | Newly listed |
| UHC Complete Care Support FG-5 (PPO C-SNP) | H2001-135-000 | MA-PD (PPO C-SNP) | Not listed | Tier 3 | PA, QL | Newly listed |
| Medica Prime Solution Thrift w/Rx (Cost) | H2450-007-000 | MA-PD (Cost) | Not listed | Tier 3 | PA, QL | Newly listed |
| Medica Prime Solution Standard w/Rx (Cost) | H2450-049-000 | MA-PD (Cost) | Not listed | Tier 3 | PA, QL | Newly listed |
| Aetna Medicare Signature Extra (PPO) | H5521-759-000 | MA-PD (PPO) | New plan ID | Tier 3 | PA, QL | New plan ID in 2027 |
| Align SecureChoice (PPO) | H8385-005-000 | MA-PD (PPO) | New plan ID | Tier 3 | PA, QL | New plan ID in 2027 |
| Align SecureChoice Gold (PPO) | H8385-006-000 | MA-PD (PPO) | New plan ID | Tier 3 | PA, QL | New plan ID in 2027 |
| Medica Advantage Select (PPO) | H8889-012-000 | MA-PD (PPO) | Not listed | Tier 3 | PA, QL | Newly listed |
| Medica Advantage Preferred (PPO) | H8889-013-000 | MA-PD (PPO) | Not listed | Tier 3 | PA, QL | Newly listed |
| Medica Advantage Value (PPO) | H8889-014-000 | MA-PD (PPO) | Not listed | Tier 3 | PA, QL | Newly listed |
| Medica Advantage Dual (PPO D-SNP) | H8889-016-000 | MA-PD (PPO D-SNP) | Not listed | Tier 3 | PA, QL | Newly listed |
| Aetna Medicare Elite (PPO) | H9431-014-000 | MA-PD (PPO) | Not listed | Tier 3 | PA, QL | Newly listed |
| Wellcare Classic (PDP) | S4802-089-000 | PDP | Not listed | Tier 2 | PA, QL | Newly listed |
| Wellcare Value Script (PDP) | S4802-158-000 | PDP | Not listed | Tier 2 | PA, QL | Newly listed |
| HealthSpring Assurance Rx (PDP) | S5715-043-000 | PDP | New plan ID | Tier 3 | PA, QL | New plan ID in 2027 |
| MedicareBlue Rx Standard (PDP) | S5743-001-000 | PDP | Not listed | Tier 3 | PA, QL | Newly listed |
| Humana Basic Rx Plan (PDP) | S5884-145-000 | PDP | Not listed | Tier 3 | PA, QL | Newly listed |
| Humana Premier Rx Plan (PDP) | S5884-171-000 | PDP | Not listed | Tier 3 | PA, QL | Newly listed |
| Humana Value Rx Plan (PDP) | S5884-204-000 | PDP | Not listed | Tier 3 | PA, QL | Newly listed |
| AARP Medicare Rx Saver from UHC (PDP) | S5921-370-000 | PDP | Not listed | Tier 3 | PA, QL | Newly listed |
Data only, not plan advice. Confirm on Medicare.gov Plan Finder or 1-800-MEDICARE.
By dosage form
The 2027 formularies list Wegovy by dosage form. A plan can cover one form and leave off or restrict another, so each form is counted on its own.
| Dosage form | Plans that list it | Restricted (of listing) | Most common tier |
|---|---|---|---|
| Auto-injector | 26 (100%) | 26 (100%) | Tier 3 |
| Oral tablet | 26 (100%) | 26 (100%) | Tier 3 |
| Pen injector | 0 (0%) | none list it | none list it |
North Dakota compared with the nation
100% of the 26 Part D plans offered in North Dakota leave Wegovy off the 2027 formulary or restrict it, against 100% nationally (the same). All 51 states are at 100% of plans restricting or leaving it off, so North Dakota is not ranked. A plan offered in several states counts in each.
2027 compared with 2026
| Measure | 2026 | 2027 | Change |
|---|---|---|---|
| Part D plans in the file | 33 | 26 | -7 |
| Plans that list it | 0 (0%) | 26 (100%) | +100 points |
| Prior authorization (of plans that list it) | 0 | 26 (100%) | no plans list it in 2026 |
| Step therapy (of plans that list it) | 0 | 0 (0%) | no plans list it in 2026 |
| Quantity limit (of plans that list it) | 0 | 26 (100%) | no plans list it in 2026 |
| Any of the three (of plans that list it) | 0 | 26 (100%) | no plans list it in 2026 |
| Not listed or restricted (of all plans) | 33 (100%) | 26 (100%) | no change |
Formulary tier
| Tier | 2026 plans | 2027 plans |
|---|---|---|
| Tier 2 | 0 | 2 (8%) |
| Tier 3 | 0 | 24 (92%) |
Plan by plan, 2026 to 2027
| Plan by plan | Plans |
|---|---|
| Same plan ID in both years | 22 |
| Listed it in 2026, not in 2027 | 0 (0%) |
| Listed it in 2027, not in 2026 | 22 (100%) |
| Moved it to a higher tier | 0 (0%) |
| Moved it to a lower tier | 0 (0%) |
| Added prior authorization | 0 (0%) |
| Added step therapy | 0 (0%) |
| Added a quantity limit | 0 (0%) |
| Added at least one of the three | 0 (0%) |
| Removed at least one of the three | 0 (0%) |
| Plan IDs new in 2027 | 4 |
| 2026 plan IDs not in the 2027 file | 13 |
The CMS summary has no count of tier moves down, so "Moved it to a lower tier" is counted from the plan rows on this page: plans with the same plan ID in both years that list Wegovy both years.
Restricted listings rose from 0 to 26, but none of the 22 plans offered in both years added prior authorization, step therapy, or a quantity limit to Wegovy. The rise comes from plan IDs that are new in 2027: 4 new plan IDs, and 4 of them restrict it. 13 plan IDs from 2026 are not in the 2027 file.
Same plan ID in both years (22) plus 2026 plan IDs not in the 2027 file (13) add up to 35, not the 33 plans offered in North Dakota in 2026, because some plans are offered in different states in 2026 and 2027. 2 plan IDs counted in both years were offered only in other states in 2026.
Wegovy in other states
- Alabama100% restrict or leave off, no changeAL
- Alaska100% restrict or leave off, no changeAK
- Arizona100% restrict or leave off, no changeAZ
- Arkansas100% restrict or leave off, no changeAR
- California100% restrict or leave off, no changeCA
- Colorado100% restrict or leave off, no changeCO
- Connecticut100% restrict or leave off, no changeCT
- Delaware100% restrict or leave off, no changeDE
- District of Columbia100% restrict or leave off, no changeDC
- Florida100% restrict or leave off, no changeFL
- Georgia100% restrict or leave off, no changeGA
- Hawaii100% restrict or leave off, no changeHI
- Idaho100% restrict or leave off, no changeID
- Illinois100% restrict or leave off, no changeIL
- Indiana100% restrict or leave off, no changeIN
- Iowa100% restrict or leave off, no changeIA
- Kansas100% restrict or leave off, no changeKS
- Kentucky100% restrict or leave off, no changeKY
- Louisiana100% restrict or leave off, no changeLA
- Maine100% restrict or leave off, no changeME
- Maryland100% restrict or leave off, no changeMD
- Massachusetts100% restrict or leave off, no changeMA
- Michigan100% restrict or leave off, no changeMI
- Minnesota100% restrict or leave off, no changeMN
- Mississippi100% restrict or leave off, no changeMS
- Missouri100% restrict or leave off, no changeMO
- Montana100% restrict or leave off, no changeMT
- Nebraska100% restrict or leave off, no changeNE
- Nevada100% restrict or leave off, no changeNV
- New Hampshire100% restrict or leave off, no changeNH
- New Jersey100% restrict or leave off, no changeNJ
- New Mexico100% restrict or leave off, no changeNM
- New York100% restrict or leave off, no changeNY
- North Carolina100% restrict or leave off, no changeNC
- Ohio100% restrict or leave off, no changeOH
- Oklahoma100% restrict or leave off, no changeOK
- Oregon100% restrict or leave off, no changeOR
- Pennsylvania100% restrict or leave off, no changePA
- Rhode Island100% restrict or leave off, no changeRI
- South Carolina100% restrict or leave off, no changeSC
- South Dakota100% restrict or leave off, no changeSD
- Tennessee100% restrict or leave off, no changeTN
- Texas100% restrict or leave off, no changeTX
- Utah100% restrict or leave off, no changeUT
- Vermont100% restrict or leave off, no changeVT
- Virginia100% restrict or leave off, no changeVA
- Washington100% restrict or leave off, no changeWA
- West Virginia100% restrict or leave off, no changeWV
- Wisconsin100% restrict or leave off, no changeWI
- Wyoming100% restrict or leave off, no changeWY
About this data
A plan here is one Part D plan as the CMS formulary files list it: contract, plan, and segment. That covers Medicare Advantage plans with drug coverage and stand-alone drug plans. A plan lists a drug when its formulary has a row for any RxNorm product of that name. When it has several, the row with the lowest tier is the one counted, and restricted means that row has prior authorization, step therapy, or a quantity limit.
A plan with no row for the drug counts as not listing it. That can be a product the file codes another way, so read a low count as a lookup result, not a coverage decision. A state counts every plan the CMS landscape file offers there. Parent organizations are named as CMS names them. The drug list is the top 200 by total Part D spending.
Source: CMS 2027 Part D formulary file (basic drugs and plan information), as of October 8, 2026. Publisher page
Source: CMS 2026 Part D formulary file (basic drugs and plan information), as of September 30, 2026. Publisher page
Source: CMS CY2027 landscape file (states and parent organizations), as of September 30, 2026. Publisher page
Source: CMS CY2026 landscape file, as of September 25, 2025. Publisher page
Source: CMS Medicare Part D Spending by Drug, 2024 data, as of June 25, 2026. Publisher page
Source: US Census Bureau 2020 ZCTA to county relationship file (ZIP lookup), as of December 9, 2021. Publisher page